REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2014

Company

Opus Genetics, Inc.

Filed

August 13, 2014

Period of Report

June 30, 2014

Accession Number

0001140361-14-032243

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →